These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6485463)

  • 21. [Localization of lipodystrophy after administration of insulin in juvenile diabetes mellitus by means of infrared thermovision].
    Stavratjev M; Stavratjevová A; Osicková L
    Cesk Pediatr; 1974 Apr; 29(4):203-5. PubMed ID: 4830781
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical picture of slow-evolving insulin-dependent diabetes mellitus]("1 1/2")].
    Grosz A; Halmos T; Pánczél P; Kautzky L; Jakab A
    Orv Hetil; 1993 Jul; 134(30):1631-4. PubMed ID: 8341540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenomics, lipodystrophy, and the metabolic syndrome.
    Hegele RA
    Trends Cardiovasc Med; 2004 May; 14(4):133-7. PubMed ID: 15177263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of lipodystrophy in Thai-HIV infected patients.
    Puttawong S; Prasithsirikul W; Vadcharavivad S
    J Med Assoc Thai; 2004 Jun; 87(6):605-11. PubMed ID: 15279336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mesenteric lipodystrophy].
    Obelar Bernal L; Ortiz de Solorzano J; Yarritu Villanueva C; Aguilera Sanz JJ; Pácheco Blanco R
    Rev Esp Enferm Dig; 1995 Sep; 87(9):658-64. PubMed ID: 7577125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Essential infantile facial lipodystrophy (a rare syndrome)].
    Collin A; Douniau R; Schepens G
    Acta Stomatol Belg; 1981; 78(1):13-27. PubMed ID: 6940430
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
    Eberting CL; Javor E; Gorden P; Turner ML; Cowen EW
    J Am Acad Dermatol; 2005 Feb; 52(2):341-4. PubMed ID: 15692481
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulogenic lipodystrophies: Their relationship to "brittle" diabetes and to insulin resistance.
    LAMAR CP
    J Am Med Assoc; 1950 Apr; 142(17):1350-53. PubMed ID: 15412140
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nonprogressive, late-onset atrophy of the cheek].
    Sonnino M; Ribuffo D; Piovano L; Cigna E; Scuderi N
    Minerva Chir; 2000 Dec; 55(12):881-5. PubMed ID: 11310188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
    Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
    Rosenbloom AL
    Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diabetes mellitus, but which type?].
    Hoekstra JB; de Koning EJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A-type lamin-linked lipodystrophies.
    Vigouroux C; Capeau J
    Novartis Found Symp; 2005; 264():166-77; discussion 177-82, 227-30. PubMed ID: 15773753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-B acute lymphoblastic leukemia in a patient with partial lipodystrophy and acanthosis nigricans.
    Franceschini P; Barisone E; Signorile F; Vardeau MP; Guala A; Franceschini D; Vivenza C; Bianchi M; Miniero R
    Panminerva Med; 1995 Dec; 37(4):248-51. PubMed ID: 8710409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study.
    Fardet L; Cabane J; Lebbé C; Morel P; Flahault A
    J Am Acad Dermatol; 2007 Oct; 57(4):604-9. PubMed ID: 17582650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical symmetrical lipomatosis with lipoatrophy of the face (mimicking HAART-related lipodystrophy).
    Castiñeiras Mato I; Almagro Sánchez M; Chouciño T; del Pozo Losada J; Fernández Jorge B; Fonseca Capdevila E
    Br J Dermatol; 2008 Jan; 158(1):190-1. PubMed ID: 17944979
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progressive lipodystrophy in childhood].
    Brezina Z
    Kinderarztl Prax; 1970 Sep; 38(9):408-12. PubMed ID: 5508072
    [No Abstract]   [Full Text] [Related]  

  • 40. Barraquer-Simons syndrome (with sensorineural deafness): a contribution to the differential diagnosis of lipodystrophy syndromes.
    Spranger S; Spranger M; Tasman AJ; Reith W; Voigtländer T; Voigtländer V
    Am J Med Genet; 1997 Sep; 71(4):397-400. PubMed ID: 9286444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.